Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Sarana Mitra Luas Tbk. (SMIL)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Sarana Mitra Luas Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Sarana Mitra Luas Tbk. diperdagangkan di Rp434 (kapitalisasi pasar 3,87 T, volume 24 jam 61,37 jt). Perbedaan utamanya: Sarana Mitra Luas Tbk. jauh lebih besar — sekitar 37,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMIL | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 3,87 T |
Volume | — | 61,37 jt |
Lot | — | 613,69 rb |
Perputaran | — | 27,25 M |
Harga Rata-rata | — | 444,04 |
Nilai Transaksi | — | 27,25 M |
Harga Ekuilibrium Indikatif | — | 434 |
Volume Ekuilibrium Indikatif | — | 46,4 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Sarana Mitra Luas Tbk.
PT Sarana Mitra Luas Tbk (the Company) was established on Sep 28, 2006 based on Notarial Deed No. 06 of Fransiska Bonita Maya Dwi Tanti, S.H., notary in Bekasi. The Company started its commercial operations in 2006.
Selengkapnya di halaman SMIL →
